Changing mortality from coronary heart disease among smokers and nonsmokers over a 20-year interval

Preventive Medicine

Volumn 26, Issue 4, 1997, Pages 441-446

  Scheidt, Stephen ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Coronary heart disease; Smoking

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CORONARY RISK; HEALTH CARE QUALITY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MORTALITY; PASSIVE SMOKING; PRIORITY JOURNAL; SMOKING;

EID: 0031194350     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1997.0185     Document Type: Article

References (36)

1. Thun M J, Day-Lally C A, Calle E E, Flanders W D, Heath C W. Excess mortality among cigarette smokers: changes in a 20-year interval. Am J Public Health. 85:1995;1223-1230.
2. M, J, Thun, C, W, Heath, Presented at the AHF/NCI/ACS Workshop; 1996 Apr 15; New York.
3. R, J, Havlik, M, Feinleib, 1979 May, Proceedings of the Conference on the Decline in Coronary Heart Disease Mortality, Bethesda, MD.
4. Higgins M W, Luepker R V. Trends in coronary heart disease mortality: the influence of medical care. 1988;Oxford Univ. Press, New York.
5. Int J Epidemiol. 18:1989;S1-S232.
6. Goldman L, Cook E F. The decline in ischemic heart disease mortality rates: an analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 101:1984;825-836.
7. Burke G L, Sprafka J M, Folsom A R, Luepker R V, Norsted S W, Blackburn H. Trends in CHD mortality, morbidity and risk factor levels from 1960 to 1986. Int J Epidemiol. 18:1989;S73-S81.
8. Lancet. 2:1988;349-360.
9. N Engl J Med. 320:1989;618-627.
10. Mueller H S, Cohen L S, Braunwald E, Forman S, Feit F, Ross A, Schweiger M, Cabin H, Davison R, Miller D, Solomon R, Knatterud G L. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction: analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. Circulation. 85:1982;1254-1264.
11. Barbash G I, White H D, Modan M. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: experience gleaned from the International Tissue Plasminogen Activator/ Streptokinase Mortality Trial. Circulation. 87:1993;53-58.
12. Mueller H S, Forman S A, Menegus M A, Cohen L S, Knatterrud G L, Braunwald E. Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. J Am Coll Cardiol. 26:1995;900-907.
13. Cairns J A, Gent M, Singer J, Finnie K J, Froggatt G M, Holder D A, Jablonsky G, Kostuk W J, Melendez L J, Myers M G, Sackett D L, Sealey B J, Tanser P H. Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med. 313:1985;1369-1375.
14. Théroux P, Waters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med. 327:1992;141-145.
15. Lewis D H, Davis J W, Archibald D G, Steinke W E, Smitherman T C, Doherty J E III, Schnaper H W, LeWinter M M, Linares E, Pouget J M, Sabharwal S C, Chesler E, DeMots H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med. 309:1983;396-403.
16. Higgins M, Thom T. Trends in CHD in the United States. Int J Epidemiol. 18:1989;S58-S66.
17. N Engl J Med. 321:1989;406-412.
18. Furburg C D, Psaty B M, Meyer J V. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 92:1995;1326-1331.
19. N Engl J Med. 325:1991;293-302.
20. N Engl J Med. 327:1992;685-691.
21. Pfeffer M A, Braunwald E, Moye L A. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial. N Engl J Med. 327:1992;669-677.
22. Pearson T A. Influences on CHD incidence and case fatality: medical management of risk factors. Int J Epidemiol. 18:1989;S217-S222.
23. Arch Intern Med. 148:1988;36-69.
24. 1988, Health United States.
25. JAMA. 257:1987;937-942.
26. US Department of Agriculture, 1985, Food consumption, prices and expenditures.
27. Stamfer M J, Hennekens C H, Manson J E, Colditz G A, Rosner B, Willett W C. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 328:1993;1444-1449.
28. Rimm E B, Stampfer M J, Ascherio A, Giovannucci E, Colditz G A, Willett W C. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 328:1993;1450-1455.
29. N Engl J Med. 321:1989;129-135.
30. Stampfer M J, Colditz G A, Willett W C, Manson J E, Rosner B, Speizer F E, Hennekens C H. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med. 325:1991;756-762.
31. Grodstein F, Stampfer M, Manson J E, Colditz G A, Willett W C, Rosner B, Speizer F E, Hennekens C H. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 335:1996;453-461.
32. Flegal K M, Troiano R P, Pamuk E R, Kuczmarski R J, Campbell S M. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med. 333:1995;1165-1170.
33. Rosenberg L, Kaufman D V, Helmrich S P, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med. 313:1985;1511-1514.
34. LaCroix A Z, Lang J, Scherr P, Wallace R B, Cornoni-Huntley J, Berkman L, Curb J D, Evans D, Hennekens C H. Smoking and mortality among older men and women in three communities. N Engl J Med. 324:1991;1619-1625.
35. Pirkle J L, Flegal K M, Bernert J T, Brody D J, Etzel R A, Maurer K R. Exposure of the US population to environmental tobacco smoke: the third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA. 275:1996;1233-1240.
36. Giovino G A, Schooley M W, Zhu B-P, Chrisnon J H, Tomar S L, Peddicord J P, Merritt R K, Husten C G, Eriksen M P. Surveillance for selected tobacco-use behaviors - United States 1900-1994. MMWR. 43:1994;1-43.